Could early norepinephrine save more septic shock patients?

NCT ID NCT07343206

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether giving the drug norepinephrine early and adjusting the dose quickly can improve survival in adults with septic shock. Researchers will compare this approach to standard care with a placebo. Six hundred participants will be monitored for 28 days to see if early treatment reduces deaths and speeds recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
norepinephrine
What this could lead to
If it works, this could establish a better way to treat septic shock, potentially saving more lives by stabilizing blood pressure faster.
What could go wrong
This is a single trial with 600 participants. Results may not apply to all patients, and norepinephrine can cause side effects like limb ischemia.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Faculty of Medicine Siriraj Hospital, Mahidol University

    RECRUITING

    Bangkok Noi, Bangkok, 10700, Thailand

  • Hatyai Hospital

    RECRUITING

    Hat Yai, Hat Yai, 90110, Thailand

  • Kalasin Hospital

    RECRUITING

    Kalasin, Changwat Kalasin, 46000, Thailand

  • Khon Kaen hospital

    RECRUITING

    Khon Kaen, Changwat Khon Kaen, 4000, Thailand

  • Maharaj Nakhon Si Thammarat Hospital

    RECRUITING

    Nakhon Si Thammarat, ์Nakhon Si Thammarat, 8000, Thailand

  • Udon Thani Hospital

    RECRUITING

    Udon Thani, Changwat Udon Thani, 41000, Thailand

More trials for these conditions

Other studies related to the condition(s) this trial covers.